 |
 |
|
Certain Lots of Heparin Sodium USP Recalled
Source: The Food and Drug Administration Covidien notified healthcare professionals of a voluntary recall of certain lots of Heparin Sodium USP because two lots of the product acquired by Covidien had a heparin-like contaminant. To date, Covidien has not received any adverse event reports related to this issue. See the manufacturer's press release for the list of specific lots of the product affected by the recall. Use of the recalled product should be discontinued immediately. Patients should contact their physician if they experience any problems associated with the use of the product. Read the complete MedWatch 2008 safety summary, including a link to the firm press release, at: http://www.fda.gov/medwatch/safety/2008/safety08.htm#heparinsodium Related News:Baxter Healthcare Recalls Heparin Sodium for Injection (02/29/08) |
 |
 |